DFDA

Plasma Exchange

Treatment for Acute Glomerulonephritis

Typical Dosage: Typically 5-7 sessions of 1-1.5 plasma volumes exchange

Effectiveness
85%
Safety Score
40%
Clinical Trials
1
Participants
5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
40
DangerousModerateSafe
Treatment Details
Dosage Range
Typically 5-7 sessions of 1-1.5 plasma volumes exchange
Time to Effect
Days to 1-2 weeks
Treatment Duration
5-10 sessions over 1-2 weeks
Evidence Quality
HIGH
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$7,500
Side Effect Mgmt:$2,000
Total Annual:$9,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$2,714/QALY
QALYs Gained
3.5
Outcome-Based Costs
Cost per Responder
$12,667
Cost per Remission
$17,273
Plasma Exchange Outcomes

for Acute Glomerulonephritis

Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+75%
Remission Rate
+55%
Common Side Effects
Hypotension
+15%
Allergic reactions
+8%
Catheter-related complications (infection, bleeding)
+7%
Coagulopathy
+7%
Electrolyte disturbances
+7%

Sources:

renalfellow.org
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov